The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-6-[4-(Cyclopropylmethyl)piperazin-1-yl]-2-(1,3,6-trimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione ID: ALA4076067
PubChem CID: 130471789
Max Phase: Preclinical
Molecular Formula: C30H31N5O3
Molecular Weight: 509.61
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc2c(cc1N1C(=O)c3cccc4c(N5CCN(CC6CC6)CC5)ccc(c34)C1=O)n(C)c(=O)n2C
Standard InChI: InChI=1S/C30H31N5O3/c1-18-15-25-26(32(3)30(38)31(25)2)16-24(18)35-28(36)21-6-4-5-20-23(10-9-22(27(20)21)29(35)37)34-13-11-33(12-14-34)17-19-7-8-19/h4-6,9-10,15-16,19H,7-8,11-14,17H2,1-3H3
Standard InChI Key: MQQWUSICUOGGBD-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 44 0 0 0 0 0 0 0 0999 V2000
5.4903 -2.9791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9175 -2.9755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2021 -2.5664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4891 -3.8065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7762 -4.2190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7770 -5.0443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4965 -5.4552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2039 -4.2193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2040 -5.0373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9084 -5.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6173 -5.0371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6172 -4.2192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9083 -3.8080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3277 -5.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3253 -6.2761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0385 -6.6894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0392 -5.0389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7528 -5.4485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7575 -6.2774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5472 -6.5292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0308 -5.8558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5398 -5.1880 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3321 -3.8073 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9074 -6.2688 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7903 -4.4020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8065 -7.3124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8558 -5.8513 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6099 -6.6869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0613 -3.8072 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0659 -2.9800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3552 -2.5683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6387 -2.9780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6375 -3.8039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3527 -4.2203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9253 -2.5635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9276 -1.7385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3460 -1.0255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5210 -1.0232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 4 2 0
13 2 1 0
2 3 2 0
3 1 1 0
8 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 9 2 0
8 9 1 0
8 13 2 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
14 15 2 0
15 16 1 0
16 19 2 0
18 17 2 0
17 14 1 0
11 14 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
12 23 2 0
10 24 2 0
22 25 1 0
20 26 1 0
21 27 2 0
15 28 1 0
5 29 1 0
29 30 1 0
29 34 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
32 35 1 0
35 36 1 0
37 36 1 0
38 37 1 0
36 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 509.61Molecular Weight (Monoisotopic): 509.2427AlogP: 3.67#Rotatable Bonds: 4Polar Surface Area: 70.79Molecular Species: BASEHBA: 7HBD: ┄#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 8.57CX LogP: 4.08CX LogD: 2.88Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.39Np Likeness Score: -1.15
References 1. Bouché L, Christ CD, Siegel S, Fernández-Montalván AE, Holton SJ, Fedorov O, Ter Laak A, Sugawara T, Stöckigt D, Tallant C, Bennett J, Monteiro O, Díaz-Sáez L, Siejka P, Meier J, Pütter V, Weiske J, Müller S, Huber KVM, Hartung IV, Haendler B.. (2017) Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains., 60 (9): [PMID:28402630 ] [10.1021/acs.jmedchem.7b00306 ]